Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001104659-25-048461 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-14 | 2025-05-12 | HBIO | Frost Mark T | Interim CFO | A - Grant | $0.00 | +100.0K | 125.0K | +400% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | A | A | 100,000 | $0.00 | 125,000 | D | — | — | (F1) Represents 100,000 restricted stock units that will vest on May 12, 2026. (F2) Includes (a) 100,000 restricted stock units that will vest on May 12, 2026, and (b) 25,000 shares of common stock beneficially owned by the Reporting Person. |